The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions of rupees, said Amitabh Kant, CEO, NITI Aayog.
Read more: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix